BREWER – The Maine Institute for Human Genetics and Health, a subsidiary of Eastern Maine Healthcare Systems, has announced the establishment of a scientific advisory board.

The board is made up of nationally recognized scientists and professors with expertise in research focusing on human cancer studies. Members will serve staggered three-year terms.

The board members are:

. Dr. Lee Helman, board chairman, scientific director of the Center for Clinical Research and head of the molecular oncology section at the National Cancer Institute in Bethesda, Md.

. Dr. Stanley Bergen of Stonington, a member of the EMHS board of directors and former founding director of the NCI Cancer Institute of New Jersey.

. Mark Dudley, a research fellow at the tumor immunology section of the surgery branch at the National Cancer Institute.

. Dr. Eugenie Kleinerman, professor and head of the division of pediatrics and a professor in the department of cancer biology at the M.D. Anderson Cancer Center at the University of Texas in Houston.

. Jude Onyia, chief scientific leader of integrative technologies at Eli Lilly & Co. in Indianapolis.

. Dr. Arnold Rabson, associate director for basic science at the NCI Cancer Institute of New Jersey and professor in the department of molecular genetics and microbiology and the department of pathology at the University of Medicine and Dentistry in New Jersey at the Robert Wood Johnson Medical School, New Brunswick, N.J.

. Dr. Clifford Rosen, senior staff scientist at The Jackson Laboratory in Bar Harbor and the Maine Medical Center Research Institute in Scarborough.

The Maine Institute for Human Genetics and Health supports research and education to decrease the risks of disease and improve the health of Maine’s rural communities.